Avestar Capital, LLC Astrazeneca PLC Transaction History

Avestar Capital, LLC

$1.12 Billion
Q4 2024

A detailed history of Avestar Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Avestar Capital, LLC holds 15,427 shares of AZN stock, worth $1.11 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

15,427

Previous 12,965 18.99%

Holding current value

$1.11 Million

Previous $1.01 Million -0.0%

% of portfolio

0.09%

Previous 0.11%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	BUY	$63.2 - $79.58 $155,598 - $195,925	2,462 Added 18.99%	15,427 $1.01 Million
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $34,271 - $39,166	447 Added 3.57%	12,965 $1.01 Million
Q2 2024 Aug 08, 2024	BUY	$66.81 - $80.83 $470,409 - $569,124	7,041 Added 128.56%	12,518 $976,000
Q1 2024 May 10, 2024	BUY	$61.03 - $69.57 $37,533 - $42,785	615 Added 12.65%	5,477 $371,000
Q4 2023 Feb 12, 2024	BUY	$61.89 - $69.28 $2,289 - $2,563	37 Added 0.77%	4,862 $327,000
Q3 2023 Oct 20, 2023	BUY	$64.85 - $71.7 $6,225 - $6,883	96 Added 2.03%	4,825 $326,000
Q2 2023 Aug 01, 2023	BUY	$69.91 - $75.81 $14,121 - $15,313	202 Added 4.46%	4,729 $338,000
Q1 2023 Apr 20, 2023	BUY	$63.15 - $71.6 $285,880 - $324,133	4,527 New	4,527 $314,000
Q4 2021 Feb 01, 2022	SELL	$54.02 - $63.83 $182,371 - $215,490	-3,376 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$48.42 - $60.18 $163,465 - $203,167	3,376 New	3,376 $202,000
Q4 2020 Feb 01, 2021	SELL	$48.52 - $58.02 $285,782 - $341,737	-5,890 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$53.07 - $61.1 $312,582 - $359,879	5,890 New	5,890 $313,000
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $91,995 - $104,262	-2,293 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$35.49 - $43.02 $22,891 - $27,747	645 Added 39.14%	2,293 $89,000
Q4 2018 Jan 25, 2019	BUY	$36.86 - $41.49 $3,391 - $3,817	92 Added 5.91%	1,648 $59,000
Q3 2018 Oct 23, 2018	BUY	$34.76 - $39.72 $16,545 - $18,906	476 Added 44.07%	1,556 $59,000
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $1,589 - $1,704	-46 Reduced 4.09%	1,080 $34,000
Q1 2018 May 10, 2018	SELL	$32.97 - $36.63 $9,198 - $10,219	-279 Reduced 19.86%	1,126 $36,000
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $45,086 - $48,865	1,405	1,405 $46,000

Others Institutions Holding AZN

# of Institutions

1,350

Shares Held

477M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $223B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.

Account

Avestar Capital, LLC Astrazeneca PLC Transaction History